A Study of TQB2450 in Subjects With Stage III Non-Small Cell Lung Cancer(NSCLC)

NCT04325763 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

315

Enrollment

INDUSTRY

Sponsor class

Conditions

Stage III Non-small-cell Lung Cancer

Interventions

DRUG: TQB2450
DRUG: Anlotinib
DRUG: TQB2450(blank)
DRUG: Anlotinib(blank)

Sponsor

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.